Tiny Gem Archives - Page 7 of 66

WednesdayMar 04, 2026 9:00 am

Reports Indicate US Military Used Anthropic’s AI in Iran Strikes

Reports indicate the U.S. military wasstill running Anthropic's AI models during strikes on Iran even after President Trump had formally ordered all federal agencies to stop using models developed by Anthropic. Axios and the Wall Street Journal both flagged the contradiction, and it immediately raised a pointed question about whether advanced artificial intelligence models can realistically be pulled from active operations once they have been built into the infrastructure of modern warfare. Journalists at both outlets reported that commanders relied on the technology throughout the large joint assault with Israel launched on Saturday. The Wall Street Journal reports that it…

MondayMar 02, 2026 10:00 am

New Study Unveils Promising Way to Conduct Brain Surgery Against Cancer

A new study may have just given brain surgeons a significantly better way to fight cancer without compromising how patients live afterward. Published in Science Advances, the research unlocks a layer of information already sitting in the operating room, one that surgeons have never had the tools to interpret until now. Awake brain mapping has anchored neurosurgical practice for generations. The procedure keeps patients conscious while surgeons deliver precise electrical pulses to targeted brain regions, monitoring responses to verbal tasks as they operate. Accurate, timely answers indicate a region is safe to remove, while hesitation or speech failure signals the opposite, and because the brain carries no pain-sensing nerves, patients feel none of…

MondayMar 02, 2026 9:00 am

Liora, a subsidiary of LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), Introduces New CEO, Brings Experience to Treating Tumors with Proton Therapy

There are several types of technologies for treating tumors with proton therapy, such as pencil beam scanning, passive scattering, and others Linac for Image Guided Hadron Therapy, LiGHT system, is believed to offer a more affordable, compact, and efficient design, along with better treatment precision than traditional technologies The system complements LIXTE’s lead clinical candidate, LB-100, which is a small-molecule PP2A inhibitor which is designed to enhance the activity of immunotherapy and chemotherapy Treating tumors with proton therapy is a highly advanced form of radiation that offers high precision, which minimizes radiation exposure for the tissue around the tumor. There…

FridayFeb 27, 2026 9:00 am

Rail Vision Ltd. (NASDAQ: RVSN) Strengthens Commercial Momentum with Next Phase of Israel Railways Collaboration

Rail Vision, Israel Railways outline next stage of ongoing relationship. The ShuntingYard system is engineered for rail-yard environments, which present unique operational challenges compared with mainline operations. The collaboration with Israel Railways will allow both parties to evaluate the technology under real-world operating conditions. As rail operators worldwide increasingly adopt advanced technologies to improve safety, efficiency and automation, real-world pilot programs are becoming an important pathway for validating new solutions under operational conditions. Reflecting this trend, Rail Vision (NASDAQ: RVSN) announced that it is advancing its strategic collaboration with Israel Railways through a new evaluation phase focused on deploying its…

ThursdayFeb 26, 2026 9:00 am

GridAI Corp. (NASDAQ: GRDX) Committed to Optimization of Energy Management to Meet Hyperscale AI Data Center Demands

With a focus on energy orchestration software rather than grid hardware or power generation, GridAI addresses the immediate need to coordinate and control energy throughout hyperscale AI campuses. With rising AI-driven electricity demand rapidly exposing the limits of traditional grid planning cycles, GridAI’s model centers on real-time coordination of existing assets and allows hyperscalers to optimize the design of new infrastructure buildout. The company’s platform operates across the entire data center campus, managing grid power, on-site generation, battery storage, and market participation, to position energy control as a financial and operational lever for large power users. For much of the…

WednesdayFeb 25, 2026 10:00 am

Engineered Nanoparticles Hold Promise in Delivering Precision Cancer Treatments

McGill University researchers have built tiny particle carriers that can shuttle cancer drugs straight to diseased lymph nodes without touching healthy tissue, reducing toxic side effects in mice compared to conventional whole-body treatment. The method tackles cancer that has spread into the lymphatic system, a particularly tough stage that typically forces surgeons to remove affected nodes despite their essential role in coordinating immune responses throughout the body. Standard immunotherapy floods the bloodstream through IV infusion, activating immune responses indiscriminately across organs and tissues in ways that can grow dangerous enough to require dose cuts that weaken treatment. McGill Biomedical Engineering Assistant Professor Guojun Chen says certain immunotherapies trigger reactions so…

WednesdayFeb 25, 2026 9:45 am

Rail Vision Ltd. (NASDAQ: RVSN) Subsidiary Advances Quantum AI Strategy with New Neural Decoder Breakthrough

Quantum Transportation’s system represents a patented prototype machine-learning-driven decoder aimed at addressing the complex challenges of universal quantum error correction. The company describes the technology as code agnostic, meaning it can generalize across multiple quantum error-correction frameworks rather than being limited to a single code family. Company leadership framed the unveiling as part of a longer-term technological exploration. Advancements in artificial intelligence and quantum computing continue to reshape how researchers approach complex computational challenges, particularly in areas such as error correction and large-scale data processing. A recent development in this space highlights the growing intersection between machine learning architectures and…

MondayFeb 23, 2026 10:30 am

Datavault AI Inc. (NASDAQ: DVLT) Expanded Digital Engagement Through Dream Bowl Meme Token, Major Event Partnership

Wellgistics sponsored Dream Bowl 2026 and participated in the Datavault AI shareholder distribution plan for the Dream Bowl 2026 meme coin. The first-ever Dream Bowl 2026 meme coin was not a financial instrument or a currency but was a digital collectible with utility tied to the event experience. Datavault AI’s broader mission centers on advancing AI-driven data experiences, valuation and monetization of digital assets within the Web3 environment. Datavault AI (NASDAQ: DVLT) gained attention for its role in an innovative digital collectible initiative tied to one of the most anticipated sporting events of early 2026. Through a sponsorship arrangement with Wellgistics…

MondayFeb 23, 2026 9:00 am

Canadian Defense Strategy Categorizes Quantum Computing as a High-Value Sector

Ottawa's latest defense industrial roadmap treats quantum computing as a strategic priority requiring government protection and accelerated development. Quantum sits alongside artificial intelligence, critical minerals, munitions, and space technologies as sectors vital for military capability and economic security. Rather than issuing a dedicated quantum plan, policymakers embedded it within a broader mobilization strategy linking research institutions, commercial developers, and defense procurement systems. Federal planners are now building mechanisms to connect university laboratories with defense contractors and military buyers. The goal is to compress the timeline from scientific breakthrough to battlefield deployment. This approach marks a policy shift from treating quantum…

MondayFeb 23, 2026 9:00 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands into Proton Therapy Through Liora Technologies, Advancing the LiGHT System for Next-Generation Cancer Care

LIXTE has acquired Liora Technologies Europe Ltd., securing its proprietary LiGHT system for advanced proton therapy treatment Liora works at the forefront of electronically controlled proton beam innovation, with its platform installed at the UK’s STFC Daresbury Laboratory These updates highlight LIXTE’s overarching mission to blend breakthrough drug development with transformative radiotherapy innovations in the global cancer fight Cancer is still one of the most widespread life-threatening diseases globally, with nearly all families affected either directly or as caregivers. Innovations in the medical ecosystem continue to gain momentum with the emergence of new immunotherapies, targeted drugs, and advanced radiation treatments.…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Category: Tiny Gem